BAXTER BROS INC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
BAXTER BROS INC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$218,212
-15.9%
13,7500.0%0.03%
-12.8%
Q2 2023$259,462
-21.0%
13,750
-83.9%
0.04%
-25.0%
Q1 2023$328,512
-22.5%
85,5500.0%0.05%
-25.7%
Q4 2022$424,000
+1.9%
85,550
-1.7%
0.07%
-5.4%
Q3 2022$416,000
+6.4%
87,0000.0%0.07%
+5.7%
Q2 2022$391,000
-5.6%
87,0000.0%0.07%
+12.9%
Q1 2022$414,000
-35.7%
87,000
+0.2%
0.06%
-33.3%
Q4 2021$644,000
+28.5%
86,800
-1.7%
0.09%
+16.2%
Q3 2021$501,000
-13.9%
88,3000.0%0.08%
-13.0%
Q2 2021$582,000
-17.2%
88,300
+1.7%
0.09%
-24.0%
Q1 2021$703,000
+24.9%
86,800
-0.6%
0.12%
+13.1%
Q4 2020$563,000
+77.0%
87,300
-1.1%
0.11%
+55.1%
Q3 2020$318,000
-21.7%
88,3000.0%0.07%
-27.4%
Q2 2020$406,000
+34.9%
88,3000.0%0.10%
+21.8%
Q1 2020$301,000
-24.8%
88,300
+12.8%
0.08%
-6.0%
Q4 2019$400,000
+111.6%
78,3000.0%0.08%
+93.0%
Q3 2019$189,000
+11.2%
78,3000.0%0.04%
+10.3%
Q2 2019$170,000
-6.6%
78,300
+16.3%
0.04%
-9.3%
Q1 2019$182,000
+31.9%
67,300
+133.7%
0.04%
+16.2%
Q4 2018$138,000
-52.7%
28,800
-6.5%
0.04%
-47.1%
Q3 2018$292,000
-2.7%
30,8000.0%0.07%
-13.6%
Q2 2018$300,000
-48.9%
30,800
-44.8%
0.08%
-49.4%
Q1 2018$587,000
+57.8%
55,800
-3.8%
0.16%
+56.9%
Q4 2017$372,000
-16.2%
58,0000.0%0.10%
-20.3%
Q3 2017$444,000
+7.8%
58,0000.0%0.13%
+3.2%
Q2 2017$412,000
+83.9%
58,0000.0%0.12%
+77.1%
Q1 2017$224,000
+128.6%
58,000
+20.8%
0.07%
+118.8%
Q4 2016$98,000
+7.7%
48,000
+41.2%
0.03%
+3.2%
Q3 2016$91,000
+56.9%
34,000
+81.8%
0.03%
+55.0%
Q2 2016$58,000
-79.4%
18,700
-9.7%
0.02%
-80.8%
Q4 2015$281,000
+4.5%
20,700
+10.7%
0.10%
+5.1%
Q3 2015$269,0000.0%18,7000.0%0.10%0.0%
Q2 2015$269,000
+61.1%
18,7000.0%0.10%
+62.3%
Q1 2015$167,00018,7000.06%
Other shareholders
IMMUNOGEN INC shareholders Q2 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders